Our Mission

Our mission is to empower oncology stakeholders and healthcare organizations by integrating innovative AI technologies, enabling them to provide superior patient care and drive advancements in cancer. 

Why Us?

Oncology is one of the most challenging, deeply investigated fields in medicine. With the breakout of AI and its accessibility, never has a time been as important to understand the intersection of technology and healthcare.

As clinicians and community leaders, we are uniquely positioned to understand the technology in the oncology market, but more importantly what is needed, what is helpful, and what is ready!

We’re invested in ensuring resources and technologies are understood and utilized to accelerate the treatment of cancer as rapidly as possible.

Whether a practicing oncologist, an administrator, or a pharmaceutical or biotech leader, TensorBlack aims to provide you with the education and guidance you need to make the footprint on advanced treatment and facilitation of care.

MEET THE TEAM

  • As an oncologist and executive clinical leader with over 20 years of experience, I am dedicated to ending cancer as we know it. A graduate of The Ohio State University College of Medicine and Public Health, I am also a Lean Six Sigma Black Belt certified professional. At St. Elizabeth Healthcare, I serve as the Executive Medical Director of Oncology Services, where I direct clinical operations, strategic planning, and the expansion of our cancer programs. I co-founded the Center for Precision Medicine & Genomic Health, leading innovative precision medicine programs and research, and established a national model cancer screening program. My efforts include planning, constructing, and fundraising for two state-of-the-art cancer centers, supporting over 60 oncology providers across six centers. As Editor-in-Chief of 'AI in Precision Oncology,' the first peer-reviewed academic journal on the subject, I work to advance knowledge and integration of AI in oncology. I am the Vice Chair of the regional American Cancer Society Board and serve on the executive board of the Association of Community Cancer Centers, an organization with over 42,000 members, contributing to advocacy, education, and innovation in the cancer community. To accelerate the integration of AI tools in cancer care, I co-founded Tensor Black, LLC, alongside other mission-driven oncology and technology partners.

  • Dr. Sanjay Juneja is a triple board certified hematologist & medical oncologist, international keynote speaker and the largest followed oncologist globally for his social & news media education as @TheOncDoc. He is the host of his own “Target Cancer: Podcast", spanning 2m+ downloads in over 110 countries; and an Editorial Board Member of the peer-reviewed journal A.I. in Precision Oncology. For his merits, Dr. Juneja was invited by the White House to participate on their Healthcare Leaders in Social Media roundtable through 2022, and in 2024 awarded by Targeted Oncology as the first recipient of their ‘2024 Oncology Icons’. Dr. Juneja has been featured in numerous media and news outlets which include CNBC, PBS, WIRED magazine, and the Washington Post. He currently practices alongside his wife in his hometown of Baton Rouge, Louisiana, where he served as service Chief of Oncology 2021-2023. 

  • David Penberthy has over three decades of clinical experience as a physician and he has been in the clinical practice of oncology since 1998 as a private practitioner and academic physician.  Dr. Penberthy understands the wider societal issues facing oncology patients and professionals in part through his position as President of the Association of Community Cancer Centers www.accc-cancer.org, a leading national education and advocacy organization, the membership of which cares for approximately 2/3rds of the oncology care delivered in the USA.

    After earning his Bachelor of Science degree in Electrical Engineering from Virginia Tech and a Doctor of Medicine degree from Virginia Commonwealth University, Dr. Penberthy completed a surgical internship at Bethesda Naval Hospital and he subsequently served as a U.S. Navy Flight Surgeon with Fighter Squadron 101 in Oceana, Virginia.  His strong interest and knowledge of technology led him to the field of Radiation Oncology.  In this field, Dr. Penberthy applies sophisticated technologies to alleviate the suffering caused by cancer, one of the most pressing medical issues of our generation. Dr. Penberthy earned an MBA degree from the Darden Graduate School of Business at the University of Virginia in 2011, a degree which effectively prepared him to run large organizations.

    Dr. Penberthy is intensely engaged with and active providing state of the art, patient centered, compassionate oncology care, an endeavor to which he has dedicated his career.  He has firsthand experience witnessing improvements in oncology care and outcomes over time. Dr. Penberthy is entrepreneurial, interested in applying next generation technology solutions to improving the health of humanity, in part by transforming health care from reactive treatment of disease, to predictive analytics and strategies for disease prevention

  • A transformative leader in healthcare, Olalekan Ajayi seamlessly blends his clinical expertise as a Doctor of Pharmacy with the strategic acumen of an MBA to champion the upskilling of the oncology workforce. Currently serving as the Chief Operating Officer at Highlands Oncology Group in Northwest Arkansas, Olalekan not only orchestrates the complex operations of this multi-specialty cancer center network but also fosters a culture of continuous learning and development. He believes that empowering teams with the latest knowledge and skills is crucial to delivering exceptional patient care and driving innovation in cancer treatment.

    Olalekan's passion for operational excellence and his commitment to upskilling are evident in his impressive track record. His ability to coach and inspire senior leaders, build high-performance teams, and instill a culture of continuous improvement is truly remarkable.

    Earlier in his career, Olalekan demonstrated his entrepreneurial spirit and dedication to education by building an oncology pharmacy program and serving as an Adjunct Faculty member at the University of Wyoming School of Pharmacy. These experiences solidified his belief in the power of mentorship and knowledge-sharing to elevate the entire oncology field.

    Olalekan's commitment to advancing cancer care and upskilling the workforce extends to his leadership role at the Association of Community Cancer Centers. As President, his theme focused on providing oncology professionals with the tools and resources they need to stay at the forefront of this rapidly evolving field.

    Olalekan Ajayi is not simply a healthcare executive; he is a catalyst for positive change, driven by a relentless pursuit of excellence, a profound dedication to improving the lives of cancer patients, and an unwavering belief in the power of a highly skilled and motivated oncology workforce.

  • Dr. Debra Patt is a practicing oncologist and breast cancer specialist in Austin, Texas, and an executive vice president of Texas Oncology with responsibilities in healthcare policy and strategic initiatives. She is an active leader in breast cancer and research in healthcare informatics driving digital healthcare tool adoption in clinical practice to improve the patient journey.

    She is the managing partner for the central Texas, Gulf, and Rio Grande Valley regions in Texas Oncology since 2023.

    Dr. Patt is the medical director for public policy for The US Oncology Network and has testified before the US Congress and Senate to protect access to care for cancer patients. She has chaired the council on legislation and the cancer committee for the Texas Medical Association.

    Dr. Patt serves as the current vice president of the Community Oncology Alliance and on the ASCO Board of Directors. She also chairs the Artificial Intelligence Task Force for ASCO and is the liaison for the clinical innovation committee.

    She lectures medical students and is a professor at Dell Medical School at The University of Texas at Austin.

  • Dr. Scott Penberthy is the Google Cloud CTO of Healthcare and Life Sciences with a focus on drug discovery and diagnostics, applying AI to revolutionize healthcare. Scott is a seasoned leader in AI, having pioneered projects like Google Cloud’s Semantic Search and Enterprise LLM products, driven by his use of GenAI to model life as tensors. These innovations aim to predict health trajectories and maintain wellness through proactive AI-driven recommendations. Previously, Scott applied cutting-edge AI techniques, including CNNs and GANs, to space sciences with NASA, leading to products like Google Cloud’s Deep Learning VM and AI Notebooks. His vast experience includes serving as CTO at PwC, where he led one of the first major public cloud migrations, transforming PwC's operations with AI-ready infrastructure. Scott holds a PhD in AI from the University of Washington and degrees from MIT, and he actively contributes to advisory boards at The Lustgarten Foundation, SETI, NASA Frontier Development Lab, Stanford, Harvard, and various AI and healthcare organizations.

  • Maureen Schnepf brings over a decade of expertise in onboarding, human resources, and operations, with a deep passion for driving growth in startups across a range of industries, including mortgage, marketing technology, and health education. Her proficiency in developing streamlined processes and building high-performing teams has been instrumental in fostering success from the ground up. Maureen excels at transforming organizational culture, ensuring that every employee feels valued, empowered, and integral to the company's mission. Her leadership is defined by a commitment to creating environments where both people and businesses can thrive.

Engagement Requests